Refractory Anti-NMDA Receptor Encephalitis in Early Pregnancy: A Case Report of Treatment Course and Pregnancy Outcomes.

Sarah FredrichCynthia WangRam NarayanLauren TardoKyle M Blackburn Steven Vernino

Published in: Neurology(R) neuroimmunology & neuroinflammation (2022)

This case illustrates the effective use of cyclophosphamide in the second trimester of pregnancy for anti-NMDAR encephalitis. The use of second-line therapies remains an individualized decision because the relative risk-to-benefit ratio in pregnant women is incompletely understood.

Keyphrases

pregnancy outcomes
pregnant women
low dose
high dose
preterm birth
combination therapy
replacement therapy